1336896 Steroid precursors F HOFFMANNLA ROCHE & CO AG 21 May 1971 [21 May 1970 (2)] 41132/72 Divided out of 1,336,895 Heading C2C The invention comprises 9#-de-A-steroids of the d or dl series having the formula wherein R is C 2-8 alkyl, and RSP1/SP and RSP2/SP are each H or Me, at least one being Me. These compounds, and also a dl-analogue thereof wherein R=RSP1/SP=RSP2/SP=Me, are prepared from the corresponding #SP9/SP-compounds by hydrogenation in the presence of Pd/BaSO 4 and HBr. dl - Trans - anti - 6 - [(3,5 - demethylisoxarol- 4 - yl)methyl] - 3a - methyl - 3,7 - dioxo - 1,2,3a,4- 5,7,8,9,9a,9b - decahydro - 3H - benz[e]indene and antecedents thereof are prepared as described in Specification 1,298,212. Reference has been directed by the Comptroller to Specifications 1,298,218 and 1,298,212.
展开▼
机译:1336896类固醇前体F HOFFMANNLA ROCHE&CO AG 1971年5月21日[1970年5月21日(2)] 41132/72从1336895税号C2C中剔除本发明包含d或dl系列的9#-de-A-类固醇,其分子式为R为C 2-8烷基,R 1 SP>和R 2 SP>分别为H或Me,至少一个为Me。这些化合物及其dl-类似物,其中R = R 1 SP> = R 2 SP> = Me,是由相应的# 9 SP>-制备的。在Pd / BaSO 4和HBr存在下,通过氢化反应生成化合物。 dl-反式-反式-6-[[(3,5--脱甲基异恶唑-4-基)甲基]]-3a-甲基-3,7-二氧-1,2,3a,4- 5,7,8,9,9a如说明书1,298,212中所述制备1,9b-十氢-3H-苯并[e]茚和其前体。主计长已对规格1,298,218和1,298,212进行了参考。
展开▼